Jersey Shore NJ
EnGeneIC Wins Innovation Award from Australian Financial Review
NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- , a clinical-stage biopharmaceutical company advancing its proprietary EDV nanocell platform for targeted cyto-immunotherapy in ca…
